ABT vs ANGO · P/E 25, rev $44.33B vs rev $292.5M
Abbott Laboratories (ABT) versus AngioDynamics Inc (ANGO) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ANGO currently screens at market cap $378.5M.
Not investment advice. Open the ABT and ANGO stock pages for the full models.
Not investment advice.